Press Releases


Veos Pharmaceuticals Selected to Present at Europe–Japan SALON Part 4, Showcasing OliQuell™ for Green Innovation


Madrid, Spain – August 21, 2025 - Veos Pharmaceuticals is proud to announce its selection to present at the Europe–Japan SALON Part 4, organized by SAKURA DEEPTECH Shibuya and the EU–Japan Centre for Industrial Cooperation, under the EU Business Hub. The event will be held in Tokyo, Japan, on September 3, 2025, and will bring together leading European and Japanese startups, corporates, and policymakers with a focus on GREEN innovation.

Veos Pharma will present OliQuell™, its breakthrough, nature-based platform derived from olive waste that provides scalable solutions for:

  • Water purification & reuse: Removing turbidity, heavy metals, agrochemicals, and stabilizing pH.
  • Biogas purification: Reducing methane (–84%) and hydrogen sulfide (–81%), while boosting oxygenation.
  • Air & emissions control: Cutting CO₂ (–50%) and VOCs, validated in pilots with Volvo, Zeekr, and IMDEA.
With proven results in Europe, Africa, and Asia, OliQuell™ aligns with Japan’s GX 2030 decarbonization goals, offering a circular, chemical-free, and cost-effective alternative to traditional filtration and chemical flocculants.

“We are honored to bring Mediterranean innovation to Japan’s stage at Europe–Japan SALON. OliQuell™ demonstrates how nature-based solutions can drive water security, clean air, and industrial sustainability in line with Japan’s green transition goals,” said Dr. Bassam Damaj, CEO of Veos Pharmaceuticals.

Veos Pharmaceuticals looks forward to building strategic partnerships in Japan across the water, biogas, and filtration sectors to support sustainable growth and cross-border collaboration.

Event Details:

📅 Date: September 3, 2025
📍 Location: Tokyo, Japan
🕔 Time: 5:00–7:30 PM JST

About Veos Pharmaceuticals

Headquartered in Madrid, Spain, Veos Pharmaceuticals is a global leader in health innovation with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life. Veos Pharma’s flagship products include Ocufresh®, BioPropello™, Oliquell™, OleoSorb™, VEOX-Preserv™, and ThymoTropin™.
For more information, contact:
Dr. Bassam Damaj
Executive Chairman
Veos Pharmaceuticals, SL
Email: info@veospharma.com
Website: www.veospharma.com